US Stock MarketDetailed Quotes

West Pharmaceutical Services (WST)

Watchlist
  • 256.550
  • -1.990-0.77%
Close Apr 10 16:00 ET
  • 256.550
  • 0.0000.00%
Post 16:48 ET
18.49BMarket Cap37.78P/E (TTM)

West Pharmaceutical Services (WST) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
6.25%3.07B
7.51%805M
7.73%804.6M
9.17%766.5M
0.37%698M
-1.92%2.89B
2.30%748.8M
-0.07%746.9M
-6.86%702.1M
-2.96%695.4M
Operating revenue
6.25%3.07B
7.51%805M
7.73%804.6M
9.17%766.5M
0.37%698M
-1.92%2.89B
2.30%748.8M
-0.07%746.9M
-6.86%702.1M
-2.96%695.4M
Cost of revenue
3.98%1.97B
5.45%501.1M
5.83%510.3M
4.34%492.6M
0.19%466.1M
4.07%1.89B
4.72%475.2M
5.03%482.2M
2.10%472.1M
4.47%465.2M
Gross profit
10.57%1.1B
11.07%303.9M
11.18%294.3M
19.09%273.9M
0.74%231.9M
-11.57%998.5M
-1.65%273.6M
-8.19%264.7M
-21.07%230M
-15.15%230.2M
Operating expense
14.79%467.9M
24.08%128.8M
21.01%119.8M
14.43%115M
0.00%104.3M
-3.37%407.6M
-4.24%103.8M
-6.07%99M
-4.19%100.5M
1.16%104.3M
Selling and administrative expenses
16.28%393.6M
25.44%107M
22.99%102.7M
15.54%95.9M
1.50%88M
-4.22%338.5M
-5.22%85.3M
-6.18%83.5M
-6.11%83M
0.81%86.7M
Research and development costs
7.53%74.3M
17.84%21.8M
10.32%17.1M
9.14%19.1M
-7.39%16.3M
1.02%69.1M
0.54%18.5M
-5.49%15.5M
6.06%17.5M
2.92%17.6M
Operating profit
7.65%636.1M
3.12%175.1M
5.31%174.5M
22.70%158.9M
1.35%127.6M
-16.47%590.9M
0.00%169.8M
-9.40%165.7M
-30.56%129.5M
-25.15%125.9M
Net non-operating interest income expense
2.41%17M
-5.36%5.3M
15.38%4.5M
40.00%3.5M
-19.57%3.7M
-12.63%16.6M
-31.71%5.6M
-33.90%3.9M
8.70%2.5M
76.92%4.6M
Non-operating interest income
-10.71%17.5M
6.25%5.1M
2.17%4.7M
-10.00%3.6M
-33.87%4.1M
-30.00%19.6M
-48.94%4.8M
-47.73%4.6M
-20.00%4M
29.17%6.2M
Non-operating interest expense
-83.33%500K
75.00%-200K
-71.43%200K
-93.33%100K
-75.00%400K
-66.67%3M
-166.67%-800K
-75.86%700K
-44.44%1.5M
-27.27%1.6M
Other net income (expense)
-137.27%-52.2M
-80.00%-18.9M
-39.22%-7.1M
-63.64%-5.4M
-570.97%-20.8M
22.54%-22M
-7.14%-10.5M
-183.33%-5.1M
15.38%-3.3M
75.97%-3.1M
Gain on sale of security
17.65%-8.4M
3.45%-2.8M
34.15%-2.7M
15.00%-1.7M
0.00%-1.2M
-8.51%-10.2M
54.69%-2.9M
-127.78%-4.1M
-566.67%-2M
-33.33%-1.2M
Special income (charges)
-319.19%-41.5M
-109.59%-15.3M
-1,400.00%-3.9M
-146.15%-3.2M
-1,093.75%-19.1M
52.17%-9.9M
-386.67%-7.3M
107.14%300K
61.76%-1.3M
86.21%-1.6M
-Less:Restructuring and merger&acquisition
1,180.77%33.3M
347.37%8.5M
376.92%3.6M
140.00%2.4M
1,780.00%18.8M
620.00%2.6M
258.33%1.9M
-285.71%-1.3M
433.33%1M
233.33%1M
-Less:Impairment of capital assets
-47.14%3.7M
----
----
----
-50.00%300K
32.08%7M
----
----
----
-68.42%600K
-Write off
1,400.00%4.5M
293.75%3.1M
-70.00%300K
166.67%800K
----
-93.02%300K
38.46%-1.6M
-71.43%1M
-80.00%300K
----
-Gain on sale of property,plant,equipment
--0
----
----
----
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
-21.05%-2.3M
-166.67%-800K
61.54%-500K
---500K
-66.67%-500K
-211.76%-1.9M
84.21%-300K
-130.95%-1.3M
----
25.00%-300K
Income before tax
2.63%600.9M
-2.06%161.5M
4.50%171.9M
21.99%157M
-13.27%110.5M
-16.12%585.5M
-1.96%164.9M
-12.03%164.5M
-30.39%128.7M
-19.32%127.4M
Income tax
13.12%121.6M
-9.51%33.3M
4.94%34M
37.90%30.2M
46.95%24.1M
-12.10%107.5M
6.67%36.8M
10.20%32.4M
-37.07%21.9M
-30.51%16.4M
Earnings from equity interest net of tax
-2.04%14.4M
95.00%3.9M
-46.15%2.1M
11.11%5M
-20.93%3.4M
-16.95%14.7M
-39.39%2M
5.41%3.9M
-10.00%4.5M
-24.56%4.3M
Net income
0.20%493.7M
1.54%132.1M
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
Net income continuous Operations
0.20%493.7M
1.54%132.1M
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
Minority interest income
Net income attributable to the parent company
0.20%493.7M
1.54%132.1M
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.20%493.7M
1.54%132.1M
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
Basic earnings per share
1.19%6.83
2.23%1.83
3.74%1.94
19.74%1.82
-21.02%1.24
-15.41%6.75
-3.24%1.79
-13.82%1.87
-26.92%1.52
-16.49%1.57
Diluted earnings per share
1.49%6.79
2.25%1.82
3.78%1.92
20.53%1.82
-20.65%1.23
-15.10%6.69
-2.73%1.78
-13.55%1.85
-26.70%1.51
-16.22%1.55
Dividend per share
4.94%0.85
4.76%0.22
5.00%0.21
5.00%0.21
5.00%0.21
5.19%0.81
5.00%0.21
5.26%0.2
5.26%0.2
5.26%0.2
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 6.25%3.07B7.51%805M7.73%804.6M9.17%766.5M0.37%698M-1.92%2.89B2.30%748.8M-0.07%746.9M-6.86%702.1M-2.96%695.4M
Operating revenue 6.25%3.07B7.51%805M7.73%804.6M9.17%766.5M0.37%698M-1.92%2.89B2.30%748.8M-0.07%746.9M-6.86%702.1M-2.96%695.4M
Cost of revenue 3.98%1.97B5.45%501.1M5.83%510.3M4.34%492.6M0.19%466.1M4.07%1.89B4.72%475.2M5.03%482.2M2.10%472.1M4.47%465.2M
Gross profit 10.57%1.1B11.07%303.9M11.18%294.3M19.09%273.9M0.74%231.9M-11.57%998.5M-1.65%273.6M-8.19%264.7M-21.07%230M-15.15%230.2M
Operating expense 14.79%467.9M24.08%128.8M21.01%119.8M14.43%115M0.00%104.3M-3.37%407.6M-4.24%103.8M-6.07%99M-4.19%100.5M1.16%104.3M
Selling and administrative expenses 16.28%393.6M25.44%107M22.99%102.7M15.54%95.9M1.50%88M-4.22%338.5M-5.22%85.3M-6.18%83.5M-6.11%83M0.81%86.7M
Research and development costs 7.53%74.3M17.84%21.8M10.32%17.1M9.14%19.1M-7.39%16.3M1.02%69.1M0.54%18.5M-5.49%15.5M6.06%17.5M2.92%17.6M
Operating profit 7.65%636.1M3.12%175.1M5.31%174.5M22.70%158.9M1.35%127.6M-16.47%590.9M0.00%169.8M-9.40%165.7M-30.56%129.5M-25.15%125.9M
Net non-operating interest income expense 2.41%17M-5.36%5.3M15.38%4.5M40.00%3.5M-19.57%3.7M-12.63%16.6M-31.71%5.6M-33.90%3.9M8.70%2.5M76.92%4.6M
Non-operating interest income -10.71%17.5M6.25%5.1M2.17%4.7M-10.00%3.6M-33.87%4.1M-30.00%19.6M-48.94%4.8M-47.73%4.6M-20.00%4M29.17%6.2M
Non-operating interest expense -83.33%500K75.00%-200K-71.43%200K-93.33%100K-75.00%400K-66.67%3M-166.67%-800K-75.86%700K-44.44%1.5M-27.27%1.6M
Other net income (expense) -137.27%-52.2M-80.00%-18.9M-39.22%-7.1M-63.64%-5.4M-570.97%-20.8M22.54%-22M-7.14%-10.5M-183.33%-5.1M15.38%-3.3M75.97%-3.1M
Gain on sale of security 17.65%-8.4M3.45%-2.8M34.15%-2.7M15.00%-1.7M0.00%-1.2M-8.51%-10.2M54.69%-2.9M-127.78%-4.1M-566.67%-2M-33.33%-1.2M
Special income (charges) -319.19%-41.5M-109.59%-15.3M-1,400.00%-3.9M-146.15%-3.2M-1,093.75%-19.1M52.17%-9.9M-386.67%-7.3M107.14%300K61.76%-1.3M86.21%-1.6M
-Less:Restructuring and merger&acquisition 1,180.77%33.3M347.37%8.5M376.92%3.6M140.00%2.4M1,780.00%18.8M620.00%2.6M258.33%1.9M-285.71%-1.3M433.33%1M233.33%1M
-Less:Impairment of capital assets -47.14%3.7M-------------50.00%300K32.08%7M-------------68.42%600K
-Write off 1,400.00%4.5M293.75%3.1M-70.00%300K166.67%800K-----93.02%300K38.46%-1.6M-71.43%1M-80.00%300K----
-Gain on sale of property,plant,equipment --0------------------0--0--0--0----
Other non- operating income (expenses) -21.05%-2.3M-166.67%-800K61.54%-500K---500K-66.67%-500K-211.76%-1.9M84.21%-300K-130.95%-1.3M----25.00%-300K
Income before tax 2.63%600.9M-2.06%161.5M4.50%171.9M21.99%157M-13.27%110.5M-16.12%585.5M-1.96%164.9M-12.03%164.5M-30.39%128.7M-19.32%127.4M
Income tax 13.12%121.6M-9.51%33.3M4.94%34M37.90%30.2M46.95%24.1M-12.10%107.5M6.67%36.8M10.20%32.4M-37.07%21.9M-30.51%16.4M
Earnings from equity interest net of tax -2.04%14.4M95.00%3.9M-46.15%2.1M11.11%5M-20.93%3.4M-16.95%14.7M-39.39%2M5.41%3.9M-10.00%4.5M-24.56%4.3M
Net income 0.20%493.7M1.54%132.1M2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M
Net income continuous Operations 0.20%493.7M1.54%132.1M2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M
Minority interest income
Net income attributable to the parent company 0.20%493.7M1.54%132.1M2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.20%493.7M1.54%132.1M2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M
Basic earnings per share 1.19%6.832.23%1.833.74%1.9419.74%1.82-21.02%1.24-15.41%6.75-3.24%1.79-13.82%1.87-26.92%1.52-16.49%1.57
Diluted earnings per share 1.49%6.792.25%1.823.78%1.9220.53%1.82-20.65%1.23-15.10%6.69-2.73%1.78-13.55%1.85-26.70%1.51-16.22%1.55
Dividend per share 4.94%0.854.76%0.225.00%0.215.00%0.215.00%0.215.19%0.815.00%0.215.26%0.25.26%0.25.26%0.2
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More